Exploring the molecular intersection for hypertension, hyperlipidemia and their comorbid conditions through

Wenjun Li1, Dan Zhou2, Yanmei Ji1

  • 1Department of Cardiovascular Surgery ICU, Yan'an Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

PubMed

Insights

This study integrated multi-omics data to map molecular signatures of hypertension and hyperlipidemia. Key metabolites and microbial changes were identified as potential biomarkers for these cardiovascular conditions.

Area of Science:

  • Cardiovascular Research
  • Metabolomics
  • Metagenomics
  • Multi-omics

Background:

  • Hypertension and hyperlipidemia significantly increase cardiovascular risk.
  • The molecular mechanisms underlying these interconnected conditions require further elucidation.
  • Integrated multi-omics approaches are needed to map complex disease signatures.

Purpose of the Study:

  • To conduct an integrated multi-omics investigation of hypertension and hyperlipidemia.
  • To unravel key molecular pathways and biomarkers associated with these conditions.
  • To identify potential diagnostic markers for comorbid hypertension and hyperlipidemia.

Main Methods:

  • Serum metabolomic and fecal metagenomic analyses were performed.
  • Samples were collected from individuals with hypertension, hyperlipidemia, both, and healthy controls.
  • Statistical and pathway analyses were employed to identify significant alterations.

Main Results:

  • Metabolomics revealed altered sphingolipids, phosphatidylcholines, and nucleic acid metabolites.
  • Metagenomics indicated depletion of Fibrobacteres and altered abundances of specific bacteria.
  • Sphingomyelin variants were identified as key diagnostic biomarkers; pathway analysis highlighted alterations in sphingolipid and amino acid metabolism.

Conclusions:

  • The study provides a comprehensive multi-omics landscape of comorbid hypertension and hyperlipidemia.
  • Identified pathways and biomarkers offer potential for precision diagnosis and treatment.
  • This research lays the groundwork for targeted cardiovascular disease management.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
781
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
465
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
735
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.6K